CA19-9 as a Dynamic Biomarker for Continuous Monitoring of Therapeutic Efficacy in Pancreatic Adenocarcinoma. - Brancato L; Osok D; Van den Bossche L; Van Cutsem E; Bates SE; Van den Bossche J; Bogers J (Cancers, 2025)